Added requirements for diagnosing an habit consist of enduring continuous cravings and obtaining drug-associated connection and social problems. A review of six placebo-controlled scientific trials with 1,134 total participants concluded that cannabinoids (nabiximols, dronabinol, and THC/CBD)